Albert Einstein College of Medicine

Projects

Projects per year 1975 2024

• 61 Not started
• 510 Active
• 3161 Finished

Projects per year

Search results

• GLYCOSYLATION MUTANTS OF ANIMAL CELLS

  Stanley, P.

  National Cancer Institute

  5/28/92 → 2/29/00

  Project: Research project

  • Chinese hamsters 100%
  • glycosyltransferases 98%
  • glycosylation 84%
  • carbohydrates 58%
  • mutants 49%

• MOLECULAR ANALYSIS OF CHEMOTAXIS IN METASTATIC CELLS

  Condeelis, J. S.

  7/1/92 → 6/30/94

  Project: Research project

  • chemotaxis 100%
  • Dictyostelium 44%
  • pseudopodia 43%
  • metastasis 22%
  • cells 21%

• CARDIAC GENE TRANSFER--HYPERTENSION RESPONSIVE ELEMENTS

  Kitsis, R. N.

  7/1/92 → 6/30/97

  Project: Research project

• CARDIAC GENE TRANSFER--HYPERTENSION RESPONSIVE ELEMENTS

  Kitsis, R. N.

  National Heart, Lung, and Blood Institute

  7/1/92 → 6/30/97

  Project: Research project

  • Myosin Heavy Chains 100%
  • Hypertension 82%
  • human MYH7 protein 61%
  • 5' Flanking Region 54%
  • Ventricular Myosins 53%

• CLINICAL RESEARCH CENTER FOR COMMUNICATIVE DISORDERS

  Ruben, R. J.

  7/1/92 → 6/30/02

  Project: Research project

  • Language 100%
  • Acoustics 72%
  • Phonetics 67%
  • Child 54%
  • Otitis Media with Effusion 45%

• FUNCTIONS OF LEUKEMIA VIRUS R REGIONS

  Lenz, J.

  National Cancer Institute

  7/1/92 → 2/28/98

  Project: Research project

• FUNCTIONS OF LEUKEMIA VIRUS R REGIONS

  Lenz, J.

  National Cancer Institute

  7/1/92 → 2/28/98

  Project: Research project

  • Murine Leukemia Viruses 100%
  • Leukemia 65%
  • DNA-Directed RNA Polymerases 59%
  • Viruses 58%
  • Preliminary Data 57%

• MUTATIONAL ANALYSIS OF AMOEBOID CHEMOTAXIS

  Segall, J. E.

  7/1/92 → 6/30/97

  Project: Research project

• MUCIN GENES--COLON CELL DIFFERENTIATION &TRASFORMATION

  Velcich, A.

  National Institutes of Health

  8/1/92 → 7/31/97

  Project: Research project

  • Mucins 100%
  • Cell Differentiation 62%
  • Colon 62%
  • Peptides 36%
  • Genes 34%

• CELL-CELL INTERACTIONS IN DEVELOPING RETINA

  Baker, N. E., Rose, S. A. & Rose, S. A.

  National Institute of General Medical Sciences

  8/1/92 → 3/31/19

  Project: Research project

  • Cell Communication 100%
  • Retina 92%
  • Photoreceptor Cells 55%
  • Eye Proteins 31%
  • Cell Survival 28%

• Cell-Cell Interactions in Developing Retina

  Baker, N. E.

  National Institute of General Medical Sciences

  8/1/92 → 3/31/19

  Project: Research project

  • Cell Communication 100%
  • Retina 92%
  • Receptor Protein-Tyrosine Kinases 44%
  • Photoreceptor Cells 36%
  • Notch Receptors 25%

• BIOCHEMICAL MECHANISM OF INSULIN RECEPTOR ENDOCYTOSIS

  Backer, J. M.

  9/1/92 → 12/31/92

  Project: Research project

  • Insulin Receptor 100%
  • Endocytosis 62%
  • Tyrosine 24%
  • Insulin 24%
  • Peptide Receptors 11%

• PHOSPHORIMAGER TM IMAGE ANALYSIS SYSTEM

  Brenowitz, M. D.

  9/1/92 → 11/30/94

  Project: Research project

  • Image analysis 100%
  • Radioactivity 71%
  • Computer workstations 65%
  • Autoradiography 45%
  • UNIX 33%

• PHOSPHORIMAGER TM IMAGE ANALYSIS SYSTEM

  Brenowitz, M. D.

  National Center for Research Resources

  9/1/92 → 11/30/94

  Project: Research project

  • Image analysis 100%
  • Radioactivity 83%
  • Computer workstations 54%
  • Autoradiography 53%
  • UNIX 38%

• PATHOGENESIS OF BRAIN DYSFUNCTION IN BATTEN'S DISEASE

  Walkley, S. U.

  National Institute of Neurological Disorders and Stroke

  9/7/92 → 8/31/96

  Project: Research project

  • Neuronal Ceroid-Lipofuscinoses 100%
  • GABAergic Neurons 55%
  • Brain 33%
  • Pyramidal Cells 22%
  • Proteolipids 21%

• PATHOGENESIS OF BRAIN DYSFUNCTION IN BATTEN DISEASE

  Walkley, S. U.

  9/7/92 → 8/31/96

  Project: Research project

  • Neuronal Ceroid-Lipofuscinoses 100%
  • GABAergic Neurons 42%
  • Brain 33%
  • Pyramidal Cells 24%
  • Mitochondrial Proton-Translocating ATPases 18%

• GENE CHANGES AND CHEMOTHERAPY FOR COLON CANCER

  Augenlicht, L. H.

  National Cancer Institute

  9/10/92 → 7/31/98

  Project: Research project

  • colorectal neoplasms 100%
  • drug therapy 81%
  • protocols 59%
  • cooperatives 55%
  • adjuvants 33%

• GENE CHANGES AND CHEMOTHERAPY FOR COLON CANCER

  Augenlicht, L. H.

  9/10/92 → 7/31/98

  Project: Research project

  • cooperatives 100%
  • protocols 55%
  • adjuvants 34%
  • colorectal neoplasms 26%
  • neoplasms 25%

• LIGAND REACTIVITY IN HEME PROTEINS

  Friedman, J. M.

  National Institute of General Medical Sciences

  9/30/92 → 8/31/97

  Project: Research project

  • ligands 100%
  • reactivity 99%
  • cryogenics 74%
  • dynamic structural analysis 50%
  • ambient temperature 38%

• MECHANISM BASED INHIBITION OF M TUBERCULOSIS ENZYMES

  Blanchard, J. S. & Rose, S. A.

  National Institute of Allergy and Infectious Diseases

  9/30/92 → 2/28/14

  Project: Research project

  • Tuberculosis 100%
  • mycothiol 93%
  • Biosynthetic Pathways 73%
  • Enzymes 66%
  • Antitubercular Agents 37%

• MUSCLE GLUCOSE TRANSPORTER GENE REGULATION

  Pessin, J. E.

  9/30/92 → 9/29/95

  Project: Research project

  • diabetes 100%
  • muscles 97%
  • glucose transporters 73%
  • insulin 49%
  • glucose 45%

• CASEIN KINASE II--EXPRESSION, STRUCTURE AND FUNCTION

  Rubin, C. S.

  National Institutes of Health

  9/30/92 → 9/29/97

  Project: Research project

  • Casein Kinase II 100%
  • Trans-Splicing 16%
  • Genes 14%
  • Complementary RNA 14%
  • Genetically Modified Animals 13%

• LIGAND REACTIVITY IN HEMEPROTEINS

  Friedman, J. M.

  9/30/92 → 8/31/97

  Project: Research project

  • ligands 100%
  • cryogenics 53%
  • proteins 45%
  • dynamic control 38%
  • dynamic structural analysis 35%

• HIV-ASSOCIATED CNS DYSFUNCTION IN PEDIATRIC AIDS

  Berman, J. W., Davies, P., Dickson, D., Chiu, F., Lyman, W. D. & Lyman, W. D.

  9/30/92 → 8/31/93

  Project: Research project

  • HIV-1 100%
  • Acquired Immunodeficiency Syndrome 70%
  • Central Nervous System 39%
  • Pediatrics 34%
  • HIV Infections 27%

• CELLULAR INTERACTIONS OF 5-FLUOROURACIL AND INTERFERON

  Schwartz, E. L.

  9/30/92 → 5/5/94

  Project: Research project

  • Interferons 100%

• Mechanism Based Inhibition of M Tuberculosis Enzymes

  Blanchard, J. S.

  National Institute of Allergy and Infectious Diseases

  9/30/92 → 2/28/14

  Project: Research project

  • Tuberculosis 100%
  • mycothiol 89%
  • Enzymes 66%
  • Biosynthetic Pathways 58%
  • Antitubercular Agents 36%

• TREATMENT OF MALIGNANT PLEURAL EFFUSIONS

  Perez-Soler, R.

  National Cancer Institute

  9/30/92 → 9/29/95

  Project: Research project

  • bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II) 100%
  • Malignant Pleural Effusion 54%
  • Liposomes 38%
  • Pleural Cavity 16%
  • Lymph Nodes 13%

• CELLULAR INTERACTIONS OF 5-FLUOROURACIL AND INTERFERON

  Schwartz, E. L.

  National Cancer Institute

  9/30/92 → 2/28/02

  Project: Research project

  • Thymidine Phosphorylase 100%
  • Fluorouracil 66%
  • Interferons 64%
  • Fluorodeoxyuridylate 8%
  • 2',5'-oligoadenylate 7%

• MUSCLE GLUCOSE TRANSPORTER GENE REGULATION

  Pessin, J. E.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/30/92 → 9/29/95

  Project: Research project

  • Facilitative Glucose Transport Proteins 100%
  • Muscles 51%
  • Genes 34%
  • DNA 32%
  • Insulin 29%

• TREATMENT OF MALIGNANT PLEURAL EFFUSIONS

  Perez-Soler, R.

  9/30/92 → 9/29/95

  Project: Research project

  • bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II) 100%
  • Liposomes 35%
  • Malignant Pleural Effusion 35%
  • Pleural Cavity 20%
  • Lymph Nodes 14%

• HGF AND TUMOR PROMOTION--AN HGF-TRANSGENIC MOUSE MODEL

  Zarnegar, R.

  National Institutes of Health

  12/10/92 → 11/30/07

  Project: Research project

  • hepatocyte growth factor 100%
  • animal models 66%
  • genetically modified organisms 59%
  • neoplasms 59%
  • Hepatocyte Growth Factor 55%

• CATALYTIC MECHANISM OF CYTOCHROME OXIDASE

  Rousseau, D. L.

  1/1/93 → 12/31/96

  Project: Research project

  • Instrumentation 100%
  • Cytochrome 89%
  • Absorptivity 65%
  • Electron Spin 56%
  • Resonance 54%

• CATALYTIC MECHANISM OF CYTOCHROME OXIDASE

  Rousseau, D. L.

  National Institute of General Medical Sciences

  1/1/93 → 12/31/96

  Project: Research project

• REGULATION OF NEUROPEPTIDE-PROCESSING ENZYMES

  Fricker, L. D.

  4/1/93 → 3/31/03

  Project: Research project

  • Carboxypeptidase H 100%
  • Enzymes 23%
  • Neuropeptides 16%
  • Opioid Peptides 9%
  • Peptides 7%

• REGULATION OF NEUROPEPTIDE PROCESSING ENZYMES

  Fricker, L. D.

  NATIONAL INSTITUTE ON DRUG ABUSE

  4/1/93 → 3/31/03

  Project: Research project

  • carboxypeptidase D 100%
  • Carboxypeptidase H 93%
  • neuropeptides 90%
  • carboxypeptidases 70%
  • peptides 56%

• ONTOGENY OF SEIZURE SUPPRESSION

  Moshe, S. L.

  4/1/93 → 3/31/95

  Project: Research project

  • Seizures 100%
  • Substantia Nigra 51%
  • Epilepsy 40%
  • Flurothyl 27%
  • Behavior Observation Techniques 21%

• ONTOGENY OF SEIZURE SUPPRESSION

  Moshe, S. L.

  Fogarty International Center

  4/1/93 → 3/31/95

  Project: Research project

  • Seizures 100%
  • Substantia Nigra 53%
  • Epilepsy 52%
  • Behavior Observation Techniques 27%
  • Bicuculline 25%

• POSTSYNAPTIC CHANGES IN GLUTAMATE SENSITIVITY DURING LTP

  Castillo, P. E.

  Fogarty International Center

  5/1/93 → 4/30/94

  Project: Research project

• POSTSYNAPTIC CHANGES IN GLUTAMATE SENSITIVITY DURING LTP

  Castillo, P. E.

  5/1/93 → 4/30/94

  Project: Research project

• PERTUSSIS, DIPHTHERIA, CHOLERA TOXINS--INHIBITOR DESIGN

  Schramm, V. L.

  National Institute of Allergy and Infectious Diseases

  7/1/93 → 1/31/05

  Project: Research project

  • Exotoxin 100%
  • Transition State 99%
  • Toxin 78%
  • Transition State Structure 53%
  • Kinetic Isotope Effect 49%

• TOXOPLASMA RIBONUCLEOTIDE REDUCTASE AS A DRUG TARGET

  Kim, K. & Taubenberger, J.

  7/1/93 → 6/30/96

  Project: Research project

  • ribonucleotide reductase 100%
  • toxoplasmosis 46%
  • Toxoplasma 36%
  • Toxoplasma gondii 20%
  • enzymes 19%

• PERTUSSIS, DIPHTHERIA, CHOLERA TOXINS-INHIBITOR DESIGN

  Schramm, V. L.

  National Institute of Allergy and Infectious Diseases

  7/1/93 → 1/31/05

  Project: Research project

  • Toxin 100%
  • Transition State 84%
  • Exotoxin 76%
  • Transition State Structure 61%
  • Kinetic Isotope Effect 43%

• DIET AND MOLECULAR GENETICS OF COLONIC CANCER

  Augenlicht, L. H.

  7/21/93 → 5/31/98

  Project: Research project

• DIET AND MOLECULAR GENETICS OF COLONIC CANCER

  Augenlicht, L. H.

  National Cancer Institute

  7/21/93 → 5/31/98

  Project: Research project

  • molecular genetics 100%
  • Volatile Fatty Acids 91%
  • neoplasms 77%
  • Colonic Neoplasms 59%
  • Mitochondrial Genes 55%

• GENE THERAPY FOR INHERITED JAUNDICE

  Roy-Chowdhury, J.

  National Institute of Diabetes and Digestive and Kidney Diseases

  8/1/93 → 7/31/09

  Project: Research project

• RIBONUCLEASE SUPERFAMILY--STRUCTURE-FUNCTION STUDIES

  Almo, S. C. & Almo, S. C.

  8/1/93 → 7/31/97

  Project: Research project

  • Pancreatic Ribonuclease 100%
  • Ribonucleases 78%
  • Catalysis 33%
  • Intercellular Signaling Peptides and Proteins 22%
  • Eosinophil-Derived Neurotoxin 22%

• Women's Interagency HIV Study (WIHS-V)

  Anastos, K. & Sharma, A.

  National Institute of Allergy and Infectious Diseases

  8/1/93 → 12/31/19

  Project: Research project

  • HIV 100%
  • HIV Infections 70%
  • Genitalia 17%
  • HIV-1 17%
  • Highly Active Antiretroviral Therapy 16%

• HETEROSYNAPTIC LONG-TERM DEPRESSION IN THE HIPPOCAMPUS

  Nicola, S. M.

  National Institute of Mental Health

  9/1/93 → 8/31/96

  Project: Research project

• MODELS OF DEMONSTRATION &EVALUATION OF WEIGHT LOSS

  Wylie-Rosett, J.

  9/1/93 → 8/31/99

  Project: Research project

  • management 100%
  • staff 94%
  • body weight 63%
  • managed care 59%
  • costs 58%

• HETEROSYNAPTIC LONG TERM DEPRESSION IN THE HIPPOCAMPUS

  Nicola, S. M.

  9/1/93 → 8/31/96

  Project: Research project